Know Cancer

or
forgot password
  • cancer clinical trials in louisville, KY

  • Efficacy of Å6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
    University of Louisville JG Brown Cancer Center
    Louisville, Kentucky 40202
    Ovarian Cancer, Primary Peritoneal Carcinoma
    Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast Cancer

    Louisville, Kentucky 40207
    Breast Neoplasms, Neoplasm Metastasis
    STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma
    James Graham Brown Cancer Center - University Of Louisville
    Louisville, Kentucky 40202
    Melanoma
    Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary CNS Germ Cell Tumor
    Kosair Children's Hospital
    Louisville, Kentucky 40202-3830
    Brain Tumor, Central Nervous System Tumor
    A Prostate Cancer Study in Men Undergoing Androgen Deprivation Therapy
    Louisville VAMC
    Louisville, Kentucky 40206
    Prostate Cancer
    A Study of STA-4783 in Combination With Weekly Paclitaxel for Treatment of Patients With Soft Tissue Sarcomas
    University of Louisville Hospital
    Louisville, Kentucky 40202
    Soft Tissue Sarcoma
    Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis
    James Graham Brown Cancer Center at University of Louisville
    Louisville, Kentucky 40202
    Sarcoma
    A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    Consultants in Blood Disorders and Cancer
    Louisville, Kentucky 40207
    Lung Cancer, Non-small-cell Lung Carcinoma
    MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma
    James Graham Brown Cancer Center

    Trial Locations
    James Graham Brown Cancer Center
    University of Louisville Hospital
    Norton Hospital
    Melanoma, Metastases
    Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)
    ImClone Investigational Site
    Louisville, Kentucky 40202
    Non-small Cell Lung Cancer
    Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)
    ImClone Investigational Site
    Louisville, Kentucky 40202
    Non-small Cell Lung Cancer
    Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes
    Kosair Children's Hospital
    Louisville, Kentucky 40202-3830
    Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Non-small Cell Lung Cancer Registry
    Kentuckiana Cancer Center, PLLC
    Louisville, Kentucky 40202
    Non-Small-Cell Lung Cancer, Pleural Effusion, Malignant
    Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
    Kosair Children's Hospital
    Louisville, Kentucky 40202-3830
    Brain and Central Nervous System Tumors
    Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium
    Local Institution
    Louisville, Kentucky
    Transitional Cell Carcinoma, Bladder Neoplasms, Kidney Neoplasms, Ureter Neoplasms, Bladder Cancer, Neoplasm, Bladder
    Study of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in Cancer
    Norton Healthcare Cancer Center
    Louisville, Kentucky 40202-5070
    Neoplasms, Pancreatic Neoplasms
    TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer
    James Graham Brown Cancer Center

    Trial Locations
    James Graham Brown Cancer Center
    University Medical Center, Inc. DBA: U of L Hospital
    Ovarian Neoplasms
    Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma
    Kosair Children's Hospital
    Louisville, Kentucky 40202-3830
    Brain and Central Nervous System Tumors
    Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer
    James Graham Brown Cancer Center

    Trial Locations
    James Graham Brown Cancer Center
    Louisville Oncology
    Lung Cancer, Non Small Cell Lung Carcinoma
    Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer
    Norton Healthcare, Inc.
    Louisville, Kentucky 40202
    Pancreatic Cancer
    Efficacy of 400 Mg Versus 800 Mg Imatinib in Chronic Myeloid Leukemia in Chronic Phase Patients - TOPS (Tyrosine Kinase Inhibitor Optimization and Selectivity)
    Lousville Oncology, Clinical Research Program M-25
    Louisville, Kentucky 40202
    Leukemia, Myeloid, Chronic Phase
    Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients
    James Graham Brown Cancer Center
    Louisville, Kentucky 40202
    Prostate Cancer
    Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care

    Louisville, Kentucky 40207
    Acute Myeloid Leukemia
    Dose Escalating Study of the Safety and Efficacy of Patupilone, q3w, in Patients With Non-small Cell Lung Cancer
    Norton Healthcare/Hospital Inc
    Louisville, Kentucky 40232-5070
    Carcinoma, Non-Small-Cell Lung
    A Phase III Trial For Patients With Metastatic Breast Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician.
    Louisville, Kentucky
    Breast Cancer, Breast Neoplasms, Cancer of the Breast
    Preoperative Therapy With Oxaliplatin/Docetaxel/Capecitabine and Radiation in Resectable Esophagus Cancer
    Consultants in Blood Disorders and Cancer
    Louisville, Kentucky 40207
    Esophagus Cancer
    Docetaxel Plus Imatinib Mesylate in Metastatic Breast Cancer
    Consultants in Blood Disorders and Cancer
    Louisville, Kentucky 40207
    Breast Cancer
    Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer
    Consultants in Blood Disorders and Cancer
    Louisville, Kentucky 40207
    Breast Cancer
    Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer
    Consultants in Blood Disorders and Cancer
    Louisville, Kentucky 40207
    Colon Cancer
    Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung Cancer
    Consultants in Blood Disorders and Cancer
    Louisville, Kentucky 40207
    Lung Cancer
    Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site
    Consultants in Blood Disorders and Cancer
    Louisville, Kentucky 40207
    Neoplasms, Unknown Primary
    Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site
    Consultants in Blood Disorders and Cancer
    Louisville, Kentucky 40207
    Neoplasms, Unknown Primary
    Study Evaluating TTI-237 in Advanced Malignant Solid Tumors.

    Louisville, Kentucky 40207
    Tumors, Neoplasms
    Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC)
    Kentuckiana Cancer Institute PLLC
    Louisville, Kentucky 40202
    Nonresectable Adrenocortical Carcinoma
    Safety and Efficacy of RK0202 in Oral Mucositis
    Commonwealth ENT
    Louisville, Kentucky 40207
    Mouth Diseases, Mouth Ulcers, Oral Mucositis, Head and Neck Cancer
    Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer
    Brown Cancer Center
    Louisville, Kentucky 40202
    Stage IV Non-small Cell Lung Cancer, Stage IIIB-pleural Effusion
    Safety and Efficacy Clinical Study of SNS-595 for Second-Line Therapy in Patients With Advanced NSCLC
    Consultants in Blood Disorders and Cancer
    Louisville, Kentucky 40207
    Carcinoma, Non-Small-Cell Lung
    Trial of Autologous, Hapten-Modified Vaccine in Patients With Stage III or IV Melanoma
    University of Louisville
    Louisville, Kentucky 40202
    Melanoma
    A Long-term Safety Study of Infliximab (Remicade)

    Louisville, Kentucky 40207
    Arthritis, Rheumatoid, Crohn Disease, Psoriasis
    Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer
    Louisville Oncology
    Louisville, Kentucky 40202
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
    Assessment of Tartrate-Resistant Acid Phosphatase (TRAP) as a Bone Resorption Marker in Stage IV Breast Cancer Patients With Bone Metastasis
    James Graham Brown Cancer Center, 529 S. Jackson St.
    Louisville, Kentucky 40202
    Breast Cancer
    Docetaxel, Irinotecan, and Carboplatin in Extensive Stage Non-Small Cell Lung Cancer
    Kentuckiana Cancer Institute
    Louisville, Kentucky 40202
    Non-small Cell Lung Cancer, Extensive Stage Unresectable
    Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer
    James Graham Brown Cancer Center
    Louisville, Kentucky 40202
    Carcinoma, Non-Small Cell Lung, Carcinoma, Small Cell Lung, Metastases
    Human Papilloma Virus DNA Self-Test
    James Graham Brown Cancer Center
    Louisville, Kentucky 40202
    Papilloma Virus, Human
    Phase II (Treatment) Study of Oxaliplatin and Capecitabine in Advanced Head and Neck Malignancies
    University of Louisville, James Graham Brown Cancer Center
    Louisville, Kentucky 40202
    Head or Neck Cancer
    Ovarian Screening Study
    James Graham Brown Cancer Center
    Louisville, Kentucky 40202
    Ovarian Cancer
    Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung Cancer
    James Graham Brown Cancer Center
    Louisville, Kentucky 40202
    Carcinoma, Non-Small Cell Lung
    A Trial in Patients With Diffuse Large-B-cell Lymphoma Comparing Pixantrone Against Doxorubicin
    Consultants in Blood Disorders and Cancer
    Louisville, Kentucky 40207
    Diffuse Large-Cell Lymphoma
    Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
    Kosair Children's Hospital
    Louisville, Kentucky 40202-3830
    Stage I Lymphoepithelioma of the Nasopharynx, Stage I Squamous Cell Carcinoma of the Nasopharynx, Stage II Lymphoepithelioma of the Nasopharynx, Stage II Squamous Cell Carcinoma of the Nasopharynx, Stage III Lymphoepithelioma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage IV Lymphoepithelioma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Nasopharynx
    3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining Study
    University of Louisville
    Louisville, Kentucky 40202
    HIV Infections
    Histamine Pharmacogenetics in Children With Atopic Dermatitis
    Kosair Charities Pediatric Clinical Research Unit
    Louisville, Kentucky 40202
    Dermatitis, Atopic
    Iscar for Second Line Treatment of Advanced Non-Small Cell Lung Cancer
    Kentuckiana Cancer Institute
    Louisville, Kentucky 40202
    Non-Small Cell Lung Cancer